We are live on ! Find out more
NVOS

Novo Integrated Sciences, Inc. Common Stock
NVOS

Delisted

NVOS was delisted on the 5th of November, 2024.

Back to rankings

6 hedge funds and large institutions have $738K invested in Novo Integrated Sciences, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.76% less ownership

Funds ownership: 2.28% → 1.51% (-0.76%)

40% less funds holding

Funds holding: 10 → 6 (-4)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

51% less capital invested

Capital invested by funds: $1.51M → $738K (-$775K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
6
Holders Change
-4
Holders Change %
-40%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$9.48K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$288K
2
Renaissance Technologies
Renaissance Technologies
New York
-$122K
3
Millennium Management
Millennium Management
New York
-$59.6K
4
Citadel Advisors
Citadel Advisors
Florida
-$30K
5
TRCT
Tower Research Capital (TRC)
New York
-$3K

NVOS Hedge Fund Activity: Q3 2021 in Review

6 of the 5,729 institutional investors tracked by Wall St. Rank reported a position in Novo Integrated Sciences, Inc. Common Stock (NVOS) for Q3 2021, worth a combined $738K — down 51% from $1.51M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NVOS and 0 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Geode Capital Management, adding an estimated $9.48K. The largest seller was Morgan Stanley, exiting entirely with an estimated $288K sold.

  • 6 institutional investors held Novo Integrated Sciences, Inc. Common Stock (NVOS) as of Q3 2021, down from 10 in Q2 2021.
  • Funds reported $738K of Novo Integrated Sciences, Inc. Common Stock stock for Q3 2021, down 51% quarter-over-quarter.
  • 0 funds opened new Novo Integrated Sciences, Inc. Common Stock positions in Q3 2021 and 4 closed out, a net change of -4 holders.
  • The largest Novo Integrated Sciences, Inc. Common Stock buyer in Q3 2021 was Geode Capital Management, an estimated $9.48K added.
  • The largest Novo Integrated Sciences, Inc. Common Stock seller in Q3 2021 was Morgan Stanley, an estimated $288K sold.

Based on aggregated 13F filings for Q3 2021.